| Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers F Cottini, T Hideshima, C Xu, M Sattler, M Dori, L Agnelli, E Ten Hacken, ... Nature medicine 20 (6), 599-606, 2014 | 327 | 2014 |
| Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma M Lionetti, M Biasiolo, L Agnelli, K Todoerti, L Mosca, S Fabris, G Sales, ... Blood, The Journal of the American Society of Hematology 114 (25), e20-e26, 2009 | 283 | 2009 |
| Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity N Amodio, MA Stamato, G Juli, E Morelli, M Fulciniti, M Manzoni, E Taiana, ... Leukemia 32 (9), 1948-1957, 2018 | 224 | 2018 |
| Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and Bcl2A1 as critical target genes R Piva, E Pellegrino, M Mattioli, L Agnelli, L Lombardi, F Boccalatte, ... The Journal of clinical investigation 116 (12), 3171-3182, 2006 | 193 | 2006 |
| Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms R Piva, L Agnelli, E Pellegrino, K Todoerti, V Grosso, I Tamagno, ... Journal of clinical oncology 28 (9), 1583-1590, 2010 | 181 | 2010 |
| Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target M Bolzoni, M Chiu, F Accardi, R Vescovini, I Airoldi, P Storti, K Todoerti, ... Blood, The Journal of the American Society of Hematology 128 (5), 667-679, 2016 | 174 | 2016 |
| A SNP microarray and FISH‐based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effect L Agnelli, L Mosca, S Fabris, M Lionetti, A Andronache, I Kwee, K Todoerti, ... Genes, Chromosomes and Cancer 48 (7), 603-614, 2009 | 158 | 2009 |
| Molecular classification of multiple myeloma: a distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations L Agnelli, S Bicciato, M Mattioli, S Fabris, D Intini, D Verdelli, L Baldini, ... Journal of clinical oncology 23 (29), 7296-7306, 2005 | 155 | 2005 |
| Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma M Mattioli, L Agnelli, S Fabris, L Baldini, F Morabito, S Bicciato, D Verdelli, ... Oncogene 24 (15), 2461-2473, 2005 | 150 | 2005 |
| An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma D Ronchetti, M Lionetti, L Mosca, L Agnelli, A Andronache, S Fabris, ... BMC medical genomics 1, 1-9, 2008 | 149 | 2008 |
| Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation N Giuliani, M Ferretti, M Bolzoni, P Storti, M Lazzaretti, B Dalla Palma, ... Leukemia 26 (6), 1391-1401, 2012 | 141 | 2012 |
| Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction P Storti, M Bolzoni, G Donofrio, I Airoldi, D Guasco, D Toscani, E Martella, ... Leukemia 27 (8), 1697-1706, 2013 | 138 | 2013 |
| Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma L Agnelli, E Mereu, E Pellegrino, T Limongi, I Kwee, E Bergaggio, ... Blood, The Journal of the American Society of Hematology 120 (6), 1274-1281, 2012 | 129 | 2012 |
| Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts I Scarfò, E Pellegrino, E Mereu, I Kwee, L Agnelli, E Bergaggio, G Garaffo, ... Blood, The Journal of the American Society of Hematology 127 (2), 221-232, 2016 | 121 | 2016 |
| Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia D Ronchetti, L Mosca, G Cutrona, G Tuana, M Gentile, S Fabris, L Agnelli, ... BMC medical genomics 6, 1-11, 2013 | 107 | 2013 |
| Revealing the impact of structural variants in multiple myeloma EH Rustad, VD Yellapantula, D Glodzik, KH Maclachlan, B Diamond, ... Blood cancer discovery 1 (3), 258-273, 2020 | 106 | 2020 |
| Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia M Lionetti, P Musto, MT Di Martino, S Fabris, L Agnelli, K Todoerti, ... Clinical cancer research 19 (12), 3130-3142, 2013 | 104 | 2013 |
| Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma E Taiana, V Favasuli, D Ronchetti, K Todoerti, F Pelizzoni, M Manzoni, ... Leukemia 34 (1), 234-244, 2020 | 102 | 2020 |
| The expression pattern of small nucleolar and small Cajal body-specific RNAs characterizes distinct molecular subtypes of multiple myeloma D Ronchetti, K Todoerti, G Tuana, L Agnelli, L Mosca, M Lionetti, S Fabris, ... Blood cancer journal 2 (11), e96-e96, 2012 | 100 | 2012 |
| miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma E Minna, P Romeo, M Dugo, L De Cecco, K Todoerti, S Pilotti, F Perrone, ... Oncotarget 7 (11), 12731, 2016 | 99 | 2016 |
